Patent · US Active

Pyrrolo[2,3-D]pyrimidine derivatives

US9549929B2 · kind B2 · utility

8Cited by
22References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2015
Grant dateJan 24, 2017
Priority date—
Expiry dateMay 18, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D207/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.